Skip to main content
Top
Published in: Journal of Cancer Research and Clinical Oncology 4/2010

01-04-2010 | Original Paper

Expression profiling of formalin-fixed paraffin embedded primary human uveal melanomas using DASL matrices

Authors: Sebastian Di Cesare, Andre Nantel, Jean-Claude Marshall, Bruno F. Fernandes, Emilia Antecka, Maria E. Orellana, Daniel Abourbih, Antonia M. Saornil, Miguel N. Burnier Jr

Published in: Journal of Cancer Research and Clinical Oncology | Issue 4/2010

Login to get access

Abstract

Purpose

Fresh biopsied ocular tumor tissues are difficult to obtain for the purpose of performing microarray experiments on extracted nucleic acids. Present technology allows for extraction of total RNA from formalin-fixed paraffin embedded (FFPE) tissue analyzed by the cDNA mediated Annealing Sectioning and Ligation (DASL) method. We aimed to correlate gene transcript differences between two uveal melanoma (UM) clinical–histopathological parameters (metastasis, cell type).

Methods

A total of 43 FFPE UM were used. The expression of RPL13a, a ribosomal protein gene, for each sample was used to evaluate the quality of RNA extracted from FFPE tissue. Gene expression values generated from the array were analyzed using the GeneSpring GX software (Agilent). Immunohistochemistry was used in order to validate transcriptional findings at the protein level.

Results

A total of 106 genes were identified with (P < 0.05, Welch ANOVA test) a difference in transcript abundance for the metastasis clinical parameter. Furthermore, we identified 64 genes with a statistically significant (P < 0.05) difference in transcript abundance between the spindle and epithelioid cell types. Each individual sample for both groups (metastasis, cell type) exhibited distinct transcriptional profiles that were separated on a PCA. Positive nuclear immunostaining for LIG4-metastasis, ErbB3-cell type was found to be associated with better patient prognosis and outcome.

Conclusions

To the best of our knowledge, this is the first time that a successful retrospective analysis has been done with UM FFPE RNA. This data may lead to future customized therapeutic targets, which may improve the now unchanged mortality rate of this particular malignancy.
Literature
go back to reference Aalto Y, Eriksson L, Seregard S et al (2001) Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Invest Ophthalmol Vis Sci 42(2):313–317PubMed Aalto Y, Eriksson L, Seregard S et al (2001) Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Invest Ophthalmol Vis Sci 42(2):313–317PubMed
go back to reference Bibikova M, Talantov D, Chudin E et al (2004) Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays. Am J Pathol 165(5):1799–1807PubMed Bibikova M, Talantov D, Chudin E et al (2004) Quantitative gene expression profiling in formalin-fixed, paraffin-embedded tissues using universal bead arrays. Am J Pathol 165(5):1799–1807PubMed
go back to reference Bibikova M, Chudin E, Arsanjani A et al (2007) Expression signatures that correlated with Gleason score and relapse in prostate cancer. Genomics 89(6):666–672CrossRefPubMed Bibikova M, Chudin E, Arsanjani A et al (2007) Expression signatures that correlated with Gleason score and relapse in prostate cancer. Genomics 89(6):666–672CrossRefPubMed
go back to reference Diener-West M, Hawkins BS, Markowitz JA et al (1992) A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol 110(2):245–250PubMed Diener-West M, Hawkins BS, Markowitz JA et al (1992) A review of mortality from choroidal melanoma. II. A meta-analysis of 5-year mortality rates following enucleation, 1966 through 1988. Arch Ophthalmol 110(2):245–250PubMed
go back to reference Ehlers JP, Harbour JW (2005) NBS1 expression as a prognostic marker in uveal melanoma. Clin Cancer Res 11(5):1849–1853CrossRefPubMed Ehlers JP, Harbour JW (2005) NBS1 expression as a prognostic marker in uveal melanoma. Clin Cancer Res 11(5):1849–1853CrossRefPubMed
go back to reference Ekberg T, Nestor M, Engstrom M et al (2005) Expression of EGFR, HER2, HER3, and HER4 in metastatic squamous cell carcinomas of the oral cavity and base of tongue. Int J Oncol 26(5):1177–1185PubMed Ekberg T, Nestor M, Engstrom M et al (2005) Expression of EGFR, HER2, HER3, and HER4 in metastatic squamous cell carcinomas of the oral cavity and base of tongue. Int J Oncol 26(5):1177–1185PubMed
go back to reference Fan JB, Yeakley JM, Bibikova M et al (2004) A versatile assay for high-throughput gene expression profiling on universal array matrices. Genome Res 14(5):878–885CrossRefPubMed Fan JB, Yeakley JM, Bibikova M et al (2004) A versatile assay for high-throughput gene expression profiling on universal array matrices. Genome Res 14(5):878–885CrossRefPubMed
go back to reference Jackson-Fisher AJ, Bellinger G, Breindel JL et al (2008) ErbB3 is required for ductal morphogenesis in the mouse mammary gland. Breast Cancer Res 10(6):R96CrossRefPubMed Jackson-Fisher AJ, Bellinger G, Breindel JL et al (2008) ErbB3 is required for ductal morphogenesis in the mouse mammary gland. Breast Cancer Res 10(6):R96CrossRefPubMed
go back to reference Jarvinen TA, Liu ET (2003) Topoisomerase IIalpha gene (TOP2A) amplification and deletion in cancer—more common than anticipated. Cytopathology 14(6):309–313CrossRefPubMed Jarvinen TA, Liu ET (2003) Topoisomerase IIalpha gene (TOP2A) amplification and deletion in cancer—more common than anticipated. Cytopathology 14(6):309–313CrossRefPubMed
go back to reference Lang AJ, Mirski SE, Cummings HJ et al (1998) Structural organization of the human TOP2A and TOP2B genes. Gene 221(2):255–266CrossRefPubMed Lang AJ, Mirski SE, Cummings HJ et al (1998) Structural organization of the human TOP2A and TOP2B genes. Gene 221(2):255–266CrossRefPubMed
go back to reference Li J, Smyth P, Flavin R et al (2007) Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol 7:36CrossRefPubMed Li J, Smyth P, Flavin R et al (2007) Comparison of miRNA expression patterns using total RNA extracted from matched samples of formalin-fixed paraffin-embedded (FFPE) cells and snap frozen cells. BMC Biotechnol 7:36CrossRefPubMed
go back to reference Liu Z, Carvajal M, Carothers Carraway CA et al (2000) Increased expression of the type 1 growth factor receptor family in the conjunctival epithelium of patients with keratoconjunctivitis sicca. Am J Ophthalmol 129(4):472–480CrossRefPubMed Liu Z, Carvajal M, Carothers Carraway CA et al (2000) Increased expression of the type 1 growth factor receptor family in the conjunctival epithelium of patients with keratoconjunctivitis sicca. Am J Ophthalmol 129(4):472–480CrossRefPubMed
go back to reference Marshall JC, Nantel A, Blanco P et al (2007) Transcriptional profiling of human uveal melanoma from cell lines to intraocular tumors to metastasis. Clin Exp Metastasis 24(5):353–362CrossRefPubMed Marshall JC, Nantel A, Blanco P et al (2007) Transcriptional profiling of human uveal melanoma from cell lines to intraocular tumors to metastasis. Clin Exp Metastasis 24(5):353–362CrossRefPubMed
go back to reference Meir T, Dror R, Yu X et al (2007) Molecular characteristics of liver metastases from uveal melanoma. Invest Ophthalmol Vis Sci 48(11):4890–4896CrossRefPubMed Meir T, Dror R, Yu X et al (2007) Molecular characteristics of liver metastases from uveal melanoma. Invest Ophthalmol Vis Sci 48(11):4890–4896CrossRefPubMed
go back to reference Mensink HW, Kilic E, Vaarwater J et al (2008) Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome. Cancer Genet Cytogenet 181(2):108–111CrossRefPubMed Mensink HW, Kilic E, Vaarwater J et al (2008) Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome. Cancer Genet Cytogenet 181(2):108–111CrossRefPubMed
go back to reference Onken MD, Worley LA, Ehlers JP et al (2004) Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 64(20):7205–7209CrossRefPubMed Onken MD, Worley LA, Ehlers JP et al (2004) Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res 64(20):7205–7209CrossRefPubMed
go back to reference Onken MD, Worley LA, Person E et al (2007) Loss of heterozygosity of chromosome 3 detected with single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanoma. Clin Cancer Res 13(10):2923–2927CrossRefPubMed Onken MD, Worley LA, Person E et al (2007) Loss of heterozygosity of chromosome 3 detected with single nucleotide polymorphisms is superior to monosomy 3 for predicting metastasis in uveal melanoma. Clin Cancer Res 13(10):2923–2927CrossRefPubMed
go back to reference Reschke M, Mihic-Probst D, van der Horst EH et al (2008) HER3 is a determinant for poor prognosis in melanoma. Clin Cancer Res 14(16):5188–5197CrossRefPubMed Reschke M, Mihic-Probst D, van der Horst EH et al (2008) HER3 is a determinant for poor prognosis in melanoma. Clin Cancer Res 14(16):5188–5197CrossRefPubMed
go back to reference Rietschel P, Panageas KS, Hanlon C et al (2005) Variates of survival in metastatic uveal melanoma. J Clin Oncol 23(31):8076–8080CrossRefPubMed Rietschel P, Panageas KS, Hanlon C et al (2005) Variates of survival in metastatic uveal melanoma. J Clin Oncol 23(31):8076–8080CrossRefPubMed
go back to reference Saraiva VS, Caissie AL, Segal L et al (2005) Immunohistochemical expression of phospho-Akt in uveal melanoma. Melanoma Res 15(4):245–250CrossRefPubMed Saraiva VS, Caissie AL, Segal L et al (2005) Immunohistochemical expression of phospho-Akt in uveal melanoma. Melanoma Res 15(4):245–250CrossRefPubMed
go back to reference Singh AD (2007) Clinical ophthalmic oncology. Saunders/Elsevier, Philadelphia, PA Singh AD (2007) Clinical ophthalmic oncology. Saunders/Elsevier, Philadelphia, PA
go back to reference Singh AD, Sisley K, Xu Y et al (2007) Reduced expression of autotaxin predicts survival in uveal melanoma. Br J Ophthalmol 91(10):1385–1392CrossRefPubMed Singh AD, Sisley K, Xu Y et al (2007) Reduced expression of autotaxin predicts survival in uveal melanoma. Br J Ophthalmol 91(10):1385–1392CrossRefPubMed
go back to reference van der Velden PA, Zuidervaart W, Hurks MH et al (2003) Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development. Int J Cancer 106(4):472–479CrossRefPubMed van der Velden PA, Zuidervaart W, Hurks MH et al (2003) Expression profiling reveals that methylation of TIMP3 is involved in uveal melanoma development. Int J Cancer 106(4):472–479CrossRefPubMed
go back to reference van Gils W, Kilic E, Bruggenwirth HT et al (2008) Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8. Melanoma Res 18(1):10–15CrossRefPubMed van Gils W, Kilic E, Bruggenwirth HT et al (2008) Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8. Melanoma Res 18(1):10–15CrossRefPubMed
go back to reference von Ahlfen S, Missel A, Bendrat K et al (2007) Determinants of RNA quality from FFPE samples. PLoS ONE 2(12):e1261CrossRef von Ahlfen S, Missel A, Bendrat K et al (2007) Determinants of RNA quality from FFPE samples. PLoS ONE 2(12):e1261CrossRef
go back to reference Wei Q, Chen L, Sheng L et al (2007) EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases. Int J Oncol 31(3):493–499PubMed Wei Q, Chen L, Sheng L et al (2007) EGFR, HER2 and HER3 expression in esophageal primary tumours and corresponding metastases. Int J Oncol 31(3):493–499PubMed
go back to reference White JS, McLean IW, Becker RL et al (2006) Correlation of comparative genomic hybridization results of 100 archival uveal melanomas with patient survival. Cancer Genet Cytogenet 170(1):29–39CrossRefPubMed White JS, McLean IW, Becker RL et al (2006) Correlation of comparative genomic hybridization results of 100 archival uveal melanomas with patient survival. Cancer Genet Cytogenet 170(1):29–39CrossRefPubMed
go back to reference Wong N, Winnie Y, Wong W et al (2008) TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance. Int J Cancer 124(3):644–652CrossRef Wong N, Winnie Y, Wong W et al (2008) TOP2A overexpression in hepatocellular carcinoma correlates with early age onset, shorter patients survival and chemoresistance. Int J Cancer 124(3):644–652CrossRef
go back to reference Zuidervaart W, van der Velden PA, Hurks MH et al (2003) Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development. Br J Cancer 89(10):1914–1919CrossRefPubMed Zuidervaart W, van der Velden PA, Hurks MH et al (2003) Gene expression profiling identifies tumour markers potentially playing a role in uveal melanoma development. Br J Cancer 89(10):1914–1919CrossRefPubMed
Metadata
Title
Expression profiling of formalin-fixed paraffin embedded primary human uveal melanomas using DASL matrices
Authors
Sebastian Di Cesare
Andre Nantel
Jean-Claude Marshall
Bruno F. Fernandes
Emilia Antecka
Maria E. Orellana
Daniel Abourbih
Antonia M. Saornil
Miguel N. Burnier Jr
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
Journal of Cancer Research and Clinical Oncology / Issue 4/2010
Print ISSN: 0171-5216
Electronic ISSN: 1432-1335
DOI
https://doi.org/10.1007/s00432-009-0692-3

Other articles of this Issue 4/2010

Journal of Cancer Research and Clinical Oncology 4/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.